Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Assets Average (2016 - 2025)

Guided Therapeutics' Assets Average history spans 14 years, with the latest figure at $1.1 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 15.23% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 15.23% decrease, with the full-year FY2025 number at $1.4 million, down 11.32% from a year prior.
  • Assets Average hit $1.1 million in Q4 2025 for Guided Therapeutics, up from $921500.0 in the prior quarter.
  • Over the last five years, Assets Average for GTHP hit a ceiling of $3.6 million in Q4 2022 and a floor of $921500.0 in Q3 2025.
  • Historically, Assets Average has averaged $1.9 million across 5 years, with a median of $1.9 million in 2021.
  • Biggest five-year swings in Assets Average: skyrocketed 239.13% in 2021 and later tumbled 51.0% in 2023.
  • Tracing GTHP's Assets Average over 5 years: stood at $1.9 million in 2021, then skyrocketed by 91.25% to $3.6 million in 2022, then crashed by 51.0% to $1.8 million in 2023, then decreased by 25.92% to $1.3 million in 2024, then decreased by 15.23% to $1.1 million in 2025.
  • Business Quant data shows Assets Average for GTHP at $1.1 million in Q4 2025, $921500.0 in Q3 2025, and $953500.0 in Q2 2025.